About this course

  • Released: 08/29/2011
  • Expires: 08/30/2013

Learning Objectives:

Upon completion of the article by Siritho et al, the participant should be able to:
  • State the prevalence of aquaporin-4 (AQP4) antibody positivity in patients with idiopathic inflammatory demyelinating CNS diseases (IIDCDs) in this study population
  • Discuss the various clinical presentations of the AQP4 antibody positive patients in this population
  • State the approximate percentage of AQP4 antibody positive patients in this population who did not meet the 2006 diagnostic criteria for neuromyelitis optica (NMO)
  • Recognize the therapeutic importance of distinguishing NMO from MS

Core Competencies:

The article by Siritho et al covers the following core competency:
  • Medical Knowledge


Learning Objectives:

Upon completion of the article by Ferman et al, the participant should be able to:
  • List the current diagnostic criteria for dementia with Lewy bodies (DLB)
  • Recognize that REM behavior disorder (RBD) is an early feature of certain neurodegenerative disorders including DLB
  • Discuss the findings from this study showing that adding RBD increases the sensitivity and specificity of diagnostic criteria for DLB

Core Competencies:

The article by Ferman et al covers the following core competency:
  • Medical Knowledge


Author Disclosures
Refer to listing above the references in each article.

THIS PAGE IS REQUIRED READING BEFORE BEGINNING ALL ACCME-ACCREDITED COURSES

ACCREDITATION STATEMENT

The American Academy of Neurology designates that participants will receive 1.5 AMA PRA Category 1 CME credits if both CME courses for the issue are completed. Physicians should only claim credit commensurate with the extent of their participation in the activity. The American Academy of Neurology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

MISSION STATEMENT/PROGRAM OBJECTIVES

After evaluating a specific article published in Neurology, participants in the CME activity should be able to demonstrate an increase in, or affirmation of, their knowledge of clinical medicine. Participants should be able to evaluate the appropriateness of the clinical information as it applies to the provision of patient care.

PARTICIPANTS

This program is designed for physicians who are involved in providing patient care and who wish to advance their current knowledge of clinical medicine.

CREDITS

The American Academy of Neurology designates that participants will receive 1.5 AMA PRA Category 1 CME credits if both CME courses for the issue are completed.

The American Academy of Neurology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians.

DISCLOSURES

Steven Lewis, MD, has received personal compensation in an editorial capacity for the National Board of Medical Examiners and the American College of Physicians; Paul Schulz, MD, has received personal compensation for activities with Pfizer.

COMMERCIAL SUPPORT

This CME program receives no commercial support.

ACCME